Search - tctmd.com

Displaying 41 - 60 of 72

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2022

Caitlin E. Cox

April 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2022

Shelley Wood

February 28, 2022

News Daily News

CABG Provides ‘Good Value’ in Ischemic Cardiomyopathy

Todd Neale

January 26, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2021

Shelley Wood

August 02, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Todd Neale

May 14, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

Todd Neale

August 03, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for August 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

What’s Going to Be Hot at ESC 2022?

TCTMD’s Top 10 Most Popular Stories for March 2022

TCTMD’s Top 10 Most Popular Stories for February 2022

CABG Provides ‘Good Value’ in Ischemic Cardiomyopathy

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

TCTMD’s Top 10 Most Popular Stories for November 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

TCTMD’s Top 10 Most Popular Stories for September 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

TCTMD’s Top 10 Most Popular Stories for July 2021

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

TCTMD’s Top 10 Most Popular Stories for September 2020

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

TCTMD’s Top 10 Most Popular Stories for August 2020

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content